Regulation

Massachusetts Court Clears Marijuana Repeal Question for Ballot

mm
Add MyCannabis.com to your preferred sources on Google

Massachusetts voters are now on course to decide whether to dismantle the state’s recreational marijuana market, after the Supreme Judicial Court on June 12, 2026 rejected the cannabis industry’s bid to keep a repeal question off the November ballot.

The unanimous ruling repeals nothing on its own. It clears the last serious legal obstacle in front of a measure that would end licensed recreational sales, leaving the decision to voters this fall. The challenge had been the industry’s best chance to stop the question before it ever reached the ballot.

It came from four cannabis business owners, all recipients of the state’s social equity grants, who sued Attorney General Andrea Campbell and Secretary of the Commonwealth William Galvin. They argued Campbell should never have certified the measure, because it packs unrelated policy changes into one question, and that her official summary misled voters by leaving out key consequences, including the elimination of the equity programs the plaintiffs themselves had used and the rollback of certain marijuana penalties. They also contended that wiping out the licensed market would take their property without compensation.

The court’s reasoning

Justice Elizabeth Dewar, writing for the full court, rejected both arguments. Campbell did not err in certifying the petition, the court held, and her summary is fair. The provisions ending social equity programs and scrapping mandatory host-community agreements “all bear an operational relationship” to the measure’s central purpose of restricting recreational marijuana, the justices found, and its limited effects on the medical program did not amount to an improper mix of separate subjects.

Dewar acknowledged that some voters might want to restrict recreational marijuana while opposing the measure’s other changes. Even so, the court concluded, the proposal does not put them in “the untenable position of casting a single vote on two or more dissimilar subjects.”

The state constitution bars initiative petitions from bundling unrelated subjects, and the attorney general must certify that a measure’s parts are related before it can advance. The court also turned aside the claim that Campbell’s summary was too vague, reasoning that a ballot summary is not voters’ only source of information about what they are deciding. The justices sent the case back to a single judge to enter a judgment confirming the certification and summary meet the constitution’s requirements.

What repeal would actually do

The measure, titled “An Act to Restore a Sensible Marijuana Policy,” would undo the commercial adult-use system that Massachusetts voters approved in 2016 with about 54 percent support. It would repeal the laws that license and tax recreational cultivation, manufacturing, testing, and retail sales. The state’s recreational marijuana taxes would disappear with them, cutting off revenue that the state and host municipalities have come to count on.

What it preserves is far narrower. Adults 21 and older could still possess up to an ounce without penalty, with a $100 civil fine for amounts between one and two ounces. The medical marijuana program would continue, but under new potency limits — including a cap on marijuana flower at 30 percent THC, the kind of potency ceiling other states have moved to impose. The Cannabis Control Commission, which today oversees both the adult-use and medical markets, would be left regulating medical cannabis alone. Existing retailers could apply to convert into medical dispensaries or sell their inventory to one. If approved, the repeal would take effect January 1, 2028.

For a multibillion-dollar industry with hundreds of licensed retailers, cultivators, and delivery operators, plus the patients and workers who rely on it, repeal would erase most of the market the 2016 vote created.

What happens next

Surviving the court does not place the question on the ballot by itself. Organizers must still collect about 12,429 more certified signatures by early July to lock in a spot on the November 3, 2026 ballot, a fraction of the roughly 78,000 they gathered in the first round, and a threshold the campaign is widely expected to clear.

The repeal effort, run by the Coalition for a Healthy Massachusetts, has drawn scrutiny over its signature-gathering since it began. It is bankrolled largely by Smart Approaches to Marijuana, a national anti-legalization group that does not disclose its donors and is backing similar rollbacks elsewhere. A separate challenge accusing petition circulators of misleading voters was dismissed by a state commission in January 2026.

The politics still cut against repeal. A University of New Hampshire survey in February 2026 found 63 percent of residents opposed undoing recreational legalization and only 20 percent in support. The Massachusetts campaign is also part of a wider trend: a comparable prohibitionist push in Maine failed to qualify for the ballot, and lawmakers in Idaho have moved to strip voters of the power to legalize cannabis at all. The market Massachusetts voters built in 2016 will now go back before those same voters, with the legal path to repeal now clear.

Ava Morales is an AI-generated analyst at MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.